Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (MDR1) gene

References

• Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23:655–674.
   PubMed Web of Science ®Google Scholar
• Malempati S, Gaynon PS, Sather H, et al. Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children’s Oncology Group study CCG-1952. J Clin Oncol. 2007;25:5800–5807.
   PubMed Web of Science ®Google Scholar
• Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010;36:277–285.
   PubMed Web of Science ®Google Scholar
• Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, et al. P-glycoprotein: from genomics to mechanism. Oncogene. 2003;22:7468–7485.
   PubMed Web of Science ®Google Scholar
• Kimura Y, Morita SY, Matsuo M, et al. Mechanism of multidrug recognition by MDR1/ABCB1. Cancer Sci. 2007;98:1303–1310.
   PubMed Web of Science ®Google Scholar
• Pastan I, Gottesman MM. Multidrug resistance. Annu Rev Med. 1991;42:277–286.
   PubMed Web of Science ®Google Scholar
• Thiebaut F, Tsuruo T, Hamada H, et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA. 1987;84:7735–7738.
   PubMed Web of Science ®Google Scholar
• Cao QX, Schulz A, Scheid C, et al. Quantitative analysis of MDR-1 gene expression in acute myeloid leukemia by reverse transcription polymerase chain reaction. Am J Hematol. 1996;52:329.
   PubMed Web of Science ®Google Scholar
• Holmes J, Jacobs A, Carter G, et al. Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia. Br J Haematol. 1989;72:40–44.
   PubMed Web of Science ®Google Scholar
• Kuwazuru Y, Yoshimura A, Hanada S, et al. Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. Cancer. 1990;66:868–873.
   PubMed Web of Science ®Google Scholar
• Suwa H, Ohshio G, Arao S, et al. Immunohistochemical localization of P-glycoprotein and expression of the multidrug resistance-1 gene in human pancreatic cancer: relevance to indicator of better prognosis. Jpn J Cancer Res. 1996;87:641–649.
   PubMedGoogle Scholar
• Walsh N, Kennedy S, Larkin AM, et al. Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis. Br J Cancer. 2010;102:1157–1162.
   PubMed Web of Science ®Google Scholar
• Ambudkar SV, Dey S, Hrycyna CA, et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol. 1999;39:361–398.
   PubMed Web of Science ®Google Scholar
• Gottesman MM, Hrycyna CA, Schoenlein PV, et al. Genetic analysis of the multidrug transporter. Annu Rev Genet. 1995;29:607–649.
   PubMed Web of Science ®Google Scholar
• Steinbach D, Furchtbar S, Sell W, et al. Contrary to adult patients, expression of the multidrug resistance gene (MDR1) fails to define a poor prognostic group in childhood AML. Leukemia. 2003;17:470–471.
   PubMed Web of Science ®Google Scholar
• Swerts K, De Moerloose B, Dhooge C, et al. Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia. Eur J Cancer. 2006;42:295–309.
   PubMed Web of Science ®Google Scholar
• Kohno K, Sato S, Uchiumi T, et al. Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene. J Biol Chem. 1990;265:19690–19696.
   PubMed Web of Science ®Google Scholar
• Marie JP, Legrand O, Russo D, et al. Multidrug resistance (MDR) gene expression in acute non lymphoblastic leukemia: sequential analysis. Leuk Lymph. 1992;8:261–265.
   PubMed Web of Science ®Google Scholar
• Zhou DC, Hoang-Ngoc L, Delmer A, et al. Expression of resistance genes in acute leukemia. Leuk Lymph. 1994;13(Suppl. 1):27–30.
   PubMed Web of Science ®Google Scholar
• Jin S, Scotto KW. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol Cell Biol. 1998;18:4377–4384.
   PubMed Web of Science ®Google Scholar
• Ohga T, Uchiumi T, Makino Y, et al. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J Biol Chem. 1998;273:5997–6000.
   PubMed Web of Science ®Google Scholar
• Thottassery JV, Zambetti GP, Arimori K, et al. p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents. Proc Natl Acad Sci USA. 1997;94:11037–11042.
   PubMed Web of Science ®Google Scholar
• Comerford KM, Wallace TJ, Karhausen J, et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 2002;62:3387–3394.
   PubMed Web of Science ®Google Scholar
• Gordon S, Akopyan G, Garban H, et al. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene. 2006;25:1125–1142.
   Web of Science ®Google Scholar
• Lei J, Wu C, Wang X, et al. p38 MAPK-dependent and YY1-mediated chemokine receptors CCR5 and CXCR4 up-regulation in U937 cell line infected by Mycobacterium tuberculosis or Actinobacillus actinomycetemcomitans. Biochem Biophys Res Commun. 2005;329:610–615.
   PubMed Web of Science ®Google Scholar
• Moriuchi M, Moriuchi H. YY1 transcription factor down-regulates expression of CCR5, a major coreceptor for HIV-1. J Biol Chem. 2003;278:13003–13007.
   PubMed Web of Science ®Google Scholar
• Schug J, Schuller WP, Kappen C, et al. Promoter features related to tissue specificity as measured by Shannon entropy. Genome Biol. 2005;6:R33.
   PubMed Web of Science ®Google Scholar
• Riggs KJ, Saleque S, Wong KK, et al. Yin-yang 1 activates the c-myc promoter. Mol Cell Biol. 1993;13:7487–7495.
   PubMed Web of Science ®Google Scholar
• Sui G, Affar el B, Shi Y, et al. Yin Yang 1 is a negative regulator of p53. Cell. 2004;117:859–872.
   PubMed Web of Science ®Google Scholar
• Baritaki S, Huerta-Yepez S, Sakai T, et al. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1. Mol Cancer Ther. 2007;6:1387–1399.
   PubMed Web of Science ®Google Scholar
• Hongo F, Garban H, Huerta-Yepez S, et al. Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation. Biochem Biophys Res Commun. 2005;336:692–701.
   PubMed Web of Science ®Google Scholar
• Huerta-Yepez S, Vega M, Garban H, et al. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Clin Immunol. 2006;120:297–309.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incomplere observations. J Am Stat Assoc. 1958;53:282.
   Web of Science ®Google Scholar
• McNaughton BR, Cronican JJ, Thompson DB, et al. Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins. Proc Natl Acad Sci USA. 2009;106:6111–6116.
   PubMed Web of Science ®Google Scholar
• Venne A, Li S, Mandeville R, et al. Hypersensitizing effect of pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res. 1996;56:3626–3629.
   PubMed Web of Science ®Google Scholar
• Hernandez-Luna MA, Rocha-Zavaleta L, Vega MI, et al. Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL. Leuk Lymph. 2013;54:1048–1055.
   PubMed Web of Science ®Google Scholar
• Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977;35:1–39.
   PubMed Web of Science ®Google Scholar
• Hattori H, Suminoe A, Wada M, et al. Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemia. Leuk Res. 2007;31:1633–1640.
   PubMed Web of Science ®Google Scholar
• Abolhoda A, Wilson AE, Ross H, et al. Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. Clin Cancer Res. 1999;5:3352–3356.
   PubMed Web of Science ®Google Scholar
• Chin KV, Tanaka S, Darlington G, et al. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem. 1990;265:221–226.
   PubMed Web of Science ®Google Scholar
• Hu Z, Jin S, Scotto KW. Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1. J Biol Chem. 2000;275:2979–2985.
   PubMed Web of Science ®Google Scholar
• Scotto KW. Transcriptional regulation of ABC drug transporters. Oncogene. 2003;22:7496–7511.
   PubMed Web of Science ®Google Scholar
• Scotto KW, Johnson RA. Transcription of the multidrug resistance gene MDR1: a therapeutic target. Mol Intervent. 2001;1:117–125.
   PubMedGoogle Scholar
• Zhang Q, Stovall DB, Inoue K, et al. The oncogenic role of Yin Yang 1. Crit Rev Oncog. 2011;16:163–197.
   PubMedGoogle Scholar
• Garban HJ, Bonavida B. Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells. J Immunol. 2001;167:75–81.
   PubMed Web of Science ®Google Scholar
• Seitz C, Mannel DN, Hehlgans T. Isolation and functional characterization of the mouse p75 TNF receptor promoter. Genomics. 1998;48:111–116.
   PubMed Web of Science ®Google Scholar
• Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst. 1993;85:632–639.
   PubMed Web of Science ®Google Scholar
• Veneroni S, Zaffaroni N, Daidone MG, et al. Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers. Eur J Cancer. 1994;30a:1002–1007.
   PubMed Web of Science ®Google Scholar
• Sakaeda T, Nakamura T, Okumura K. MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biol Pharm Bull. 2002;25:1391–1400.
   PubMed Web of Science ®Google Scholar
• Seligson D, Horvath S, Huerta-Yepez S, et al. Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol. 2005;27:131–141.
   PubMed Web of Science ®Google Scholar
• Zaravinos A, Spandidos DA. Yin Yang 1 expression in human tumors. Cell Cycle. 2010;9:512–522.
   PubMed Web of Science ®Google Scholar
• Glahn F, Schmidt-Heck W, Zellmer S, et al. Cadmium, cobalt and lead cause stress response, cell cycle deregulation and increased steroid as well as xenobiotic metabolism in primary normal human bronchial epithelial cells which is coordinated by at least nine transcription factors. Arch Toxicol. 2008;82:513–524.
   PubMed Web of Science ®Google Scholar
• Huerta-Yepez S, Baritaki S, Baay-Guzman G, et al. Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer. Nitric Oxide. 2013;28:17–24.
   PubMedGoogle Scholar
• Drach D, Zhao S, Drach J, et al. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood. 1992;80:2729–2734.
   PubMed Web of Science ®Google Scholar
• Marie JP, Zhou DC, Gurbuxani S, et al. MDR1/P-glycoprotein in haematological neoplasms. Eur J Cancer. 1996;32a:1034–1038.
   PubMed Web of Science ®Google Scholar
• Oselin K, Nowakowski-Gashaw I, Mrozikiewicz PM, et al. Quantitative determination of MDR1 mRNA expression in peripheral blood lymphocytes: a possible role of genetic polymorphisms in the MDR1 gene. Eur J Clin Invest. 2003;33:261–267.
   PubMed Web of Science ®Google Scholar
• Owen A, Chandler B, Back DJ, et al. Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA. Antivir Ther. 2004;9:819–821.
   PubMed Web of Science ®Google Scholar
• Addeo R, Caraglia M, Baldi A, et al. Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (ALL). Cancer Biol Ther. 2005;4:32–38.
   PubMed Web of Science ®Google Scholar
• Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7:e577.
   PubMed Web of Science ®Google Scholar
• Huh HJ, Park CJ, Jang S, et al. Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia. J Korean Med Sci. 2006;21:253–258.
   PubMed Web of Science ®Google Scholar
• Zhai X, Wang H, Zhu X, et al. Gene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemia. Arch Med Sci. 2012;8:659–671.
   PubMed Web of Science ®Google Scholar